In recent news, Baird analyst Vikram Kesavabhotla has adjusted the price target for Doximity (DOCS, Financial), a leading digital platform for medical professionals. The updated price target has been lowered from $87.00 to $65.00, reflecting a decrease of approximately 25.29%.
Despite the adjustment in the price target, Baird maintains its "Outperform" rating for Doximity (DOCS, Financial). This indicates that the stock is expected to perform better than the overall market or sector in the foreseeable future. The consistent "Outperform" rating highlights the firm's continued confidence in Doximity's potential, albeit with a revised price outlook.
The changes in the price target and the maintained rating come amidst fluctuating market trends and evolving business strategies within the healthcare technology industry. Investors and stakeholders of Doximity (DOCS, Financial) will be keenly observing any further updates on the company's performance and market conditions.
Wall Street Analysts Forecast
Based on the one-year price targets offered by 17 analysts, the average target price for Doximity Inc (DOCS, Financial) is $63.24 with a high estimate of $88.00 and a low estimate of $50.00. The average target implies an upside of 17.60% from the current price of $53.77. More detailed estimate data can be found on the Doximity Inc (DOCS) Forecast page.
Based on the consensus recommendation from 20 brokerage firms, Doximity Inc's (DOCS, Financial) average brokerage recommendation is currently 2.4, indicating "Outperform" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
Based on GuruFocus estimates, the estimated GF Value for Doximity Inc (DOCS, Financial) in one year is $55.38, suggesting a upside of 2.99% from the current price of $53.77. GF Value is GuruFocus' estimate of the fair value that the stock should be traded at. It is calculated based on the historical multiples the stock has traded at previously, as well as past business growth and the future estimates of the business' performance. More detailed data can be found on the Doximity Inc (DOCS) Summary page.
